Cargando…

Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men

Ex vivo studies have shown that the gastrin releasing peptide receptor (GRPr) is overexpressed on almost all primary prostate cancers, making it a promising target for prostate cancer imaging and targeted radiotherapy. Methods: Biodistribution, dosimetry and tumor uptake of the GRPr antagonist (64)C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wieser, Gesche, Mansi, Rosalba, Grosu, Anca L., Schultze-Seemann, Wolfgang, Dumont-Walter, Rebecca A., Meyer, Philipp T., Maecke, Helmut R., Reubi, Jean Claude, Weber, Wolfgang A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Short Research Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936293/ https://www.ncbi.nlm.nih.gov/pubmed/24578724 http://dx.doi.org/10.7150/thno.7324

Ejemplares similares

Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET
por: Stoykow, Christian, et al.
Publicado: (2016)

Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer
por: Jilg, Cordula A, et al.
Publicado: (2014)

Gastrin-Releasing Peptide Receptor Antagonist [(68)Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer
por: Michalski, Kerstin, et al.
Publicado: (2021)

Overexpression of Gastrin-Releasing Peptide Receptors in Tumor-Associated Blood Vessels of Human Ovarian Neoplasms
por: Fleischmann, Achim, et al.
Publicado: (2007)

Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors
por: Zhang, Hanwen, et al.
Publicado: (2012)

Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue
por: Lau, Joseph, et al.
Publicado: (2019)

Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN(7–14) and Antagonist RM26
por: Cheng, Siyuan, et al.
Publicado: (2017)

The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist
por: Abiraj, Keelara, et al.
Publicado: (2018)

Positron Emission Tomography (PET) in Oncology
por: Gallamini, Andrea, et al.
Publicado: (2014)

Comparative biodistribution of 12 (111)In-labelled gastrin/CCK2 receptor-targeting peptides
por: Laverman, Peter, et al.
Publicado: (2011)

Single punch, double biopsy
por: Krönig, Malte, et al.
Publicado: (2016)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison
por: Zamboglou, Constantinos, et al.
Publicado: (2016)

In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies
por: Chatalic, Kristell L.S., et al.
Publicado: (2016)

Myelin positron emission tomography (PET) imaging in multiple sclerosis
por: de Paula Faria, Daniele
Publicado: (2020)

Fluorinated carbohydrates for (18)F-positron emission tomography (PET)
por: Campbell, Emma, et al.
Publicado: (2023)

Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties
por: Kossatz, Susanne, et al.
Publicado: (2013)

Imaging Inflammation with Positron Emission Tomography
por: Iking, Janette, et al.
Publicado: (2021)

CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders.
por: Jensen, R. T.
Publicado: (1996)

Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth.
por: Watson, S. A., et al.
Publicado: (1992)

Antiproliferative Effect of a Novel Cholecystokinin‐B/Gastrin Receptor Antagonist, YM022
por: Murayama, Tohru, et al.
Publicado: (1996)

The role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: a study with the specific gastrin receptor antagonist AG-041R.
por: Chiba, T., et al.
Publicado: (1998)

Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial
por: Kirste, Simon, et al.
Publicado: (2022)

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients
por: Zinzani, P L, et al.
Publicado: (2004)

State of the art of Positron Emission Tomography (PET) technology and current challenges
por: Conti, Maurizio
Publicado: (2021)

The AX-PET experiment: A demonstrator for an axial Positron Emission Tomograph
por: Bolle, E, et al.
Publicado: (2013)

Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors
por: Wicki, Andreas, et al.
Publicado: (2014)

Comparison of (68)Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology
por: Zamboglou, Constantinos, et al.
Publicado: (2017)

Comparison of Manual and Semi-Automatic [(18)F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
por: Spohn, Simon K. B., et al.
Publicado: (2020)

Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy
por: Peng, Shuman, et al.
Publicado: (2023)

Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics
por: Abouzayed, Ayman, et al.
Publicado: (2023)

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2021)

Gastrin and Gastric Cancer
por: Waldum, Helge L., et al.
Publicado: (2017)

The Biological Effects of Gastrin
por: Bennett, A.
Publicado: (1968)

Gastrin and Gastric Cancer
por: Smith, Jill P., et al.
Publicado: (2017)

Gastrin and the Moderate Hypergastrinemias
por: Rehfeld, Jens F.
Publicado: (2021)

Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil
por: Rischke, Hans Christian, et al.
Publicado: (2012)

Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging
por: Li, Zibo, et al.
Publicado: (2011)

Photo-Detectors for Time of Flight Positron Emission Tomography (ToF-PET)
por: Spanoudaki, Virginia Ch., et al.
Publicado: (2010)

Positron emission tomography (PET) in primary prostate cancer staging and risk assessment
por: Bednarova, Sandra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v3ss33vtokmhqg7s93q51ra18v